PubMed

Platelet thrombin receptor antagonism and atherothrombosis.

Angiolillo DJ, Capodanno D, Goto S.

Eur Heart J. 2009 Nov 30. [Epub ahead of print]PMID: 19948715 [PubMed - as supplied by publisher]Related articles

Platelet Inhibition with Cangrelor in Patients Undergoing PCI.

Harrington RA, Stone GW, McNulty S, White HD, Lincoff AM, Gibson CM, Pollack CV Jr, Montalescot G, Mahaffey KW, Kleiman NS, Goodman SG, Amine M, Angiolillo DJ, Becker RC, Chew DP, French WJ, Leisch F, Parikh KH, Skerjanec S, Bhatt DL.

N Engl J Med. 2009 Nov 17. [Epub ahead of print]PMID: 19915221 [PubMed - as supplied by publisher]Related articlesFree article

Platelet monitoring for PCI.

Capodanno D, Angiolillo DJ.

Hamostaseologie. 2009 Sep;29(4):376-80.PMID: 19882078 [PubMed - in process]Related articles

Cangrelor: a review on its mechanism of action and clinical development.

Ferreiro JL, Ueno M, Angiolillo DJ.

Expert Rev Cardiovasc Ther. 2009 Oct;7(10):1195-201.PMID: 19814662 [PubMed - in process]Related articles

Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: validation with endomyocardial sampling in cardiac allografts.

Escaned J, Flores A, García-Pavía P, Segovia J, Jimenez J, Aragoncillo P, Salas C, Alfonso F, Hernández R, Angiolillo DJ, Jiménez-Quevedo P, Bañuelos C, Alonso-Pulpón L, Macaya C.

Circulation. 2009 Oct 20;120(16):1561-8. Epub 2009 Oct 5.PMID: 19805652 [PubMed - indexed for MEDLINE]Related articles

Investigations on 5-HT4 Receptor Expression and Effects of Tegaserod on Human Platelet Aggregation In Vitro.

Serebruany VL, Mouelhi ME, Pfannkuche HJ, Rose K, Marro M, Angiolillo DJ.

Am J Ther. 2009 Sep 22. [Epub ahead of print]PMID: 19797939 [PubMed - as supplied by publisher]Related articles

Pharmacogenetics in cardiovascular antithrombotic therapy.

Marín F, González-Conejero R, Capranzano P, Bass TA, Roldán V, Angiolillo DJ.

J Am Coll Cardiol. 2009 Sep 15;54(12):1041-57. Review.PMID: 19744613 [PubMed - indexed for MEDLINE]Related articles

Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention.

Ferreiro JL, Gómez-Hospital JA, Cequier AR, Angiolillo DJ, Roura G, Teruel L, Maristany J, Gómez-Lara J, Jara F, Bass TA, Esplugas E.

Int J Cardiol. 2009 Sep 2. [Epub ahead of print]PMID: 19732979 [PubMed - as supplied by publisher]Related articles

Clopidogrel response variability: current status and future directions.

Ferreiro JL, Angiolillo DJ.

Thromb Haemost. 2009 Jul;102(1):7-14. Review. No abstract available. PMID: 19572061 [PubMed - indexed for MEDLINE]Related articles

Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.

Valgimigli M, Campo G, de Cesare N, Meliga E, Vranckx P, Furgieri A, Angiolillo DJ, Sabatè M, Hamon M, Repetto A, Colangelo S, Brugaletta S, Parrinello G, Percoco G, Ferrari R; Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators.

Circulation. 2009 Jun 30;119(25):3215-22. Epub 2009 Jun 15.PMID: 19528337 [PubMed - indexed for MEDLINE]Related articles

Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus.

Angiolillo DJ, Suryadevara S.

Best Pract Res Clin Endocrinol Metab. 2009 Jun;23(3):375-88. Review.PMID: 19520310 [PubMed - indexed for MEDLINE]Related articles

Antiplatelet therapy: Clopidogrel plus PPIs-a dangerous combination?

Ferreiro JL, Angiolillo DJ.

Nat Rev Cardiol. 2009 Jun;6(6):392-4.PMID: 19471283 [PubMed - indexed for MEDLINE]Related articles

Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial.

Suzuki N, Angiolillo DJ, Tannenbaum MA, Driesman MH, Smith C, Bikkina M, Meckel CR, Morales CE, Xenopoulos NP, Coletta JE, Bezerra HG, Bass TA, Costa MA.

Catheter Cardiovasc Interv. 2009 Jun 1;73(7):890-7.PMID: 19455662 [PubMed - indexed for MEDLINE]Related articles

Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization.

Cola C, Brugaletta S, Martín Yuste V, Campos B, Angiolillo DJ, Sabaté M.

Vasc Health Risk Manag. 2009;5(1):101-19. Epub 2009 Apr 8. Review.PMID: 19436654 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.

Michelson AD, Frelinger AL 3rd, Braunwald E, Downey WE, Angiolillo DJ, Xenopoulos NP, Jakubowski JA, Li Y, Murphy SA, Qin J, McCabe CH, Antman EM, Wiviott SD; TRITON-TIMI 38 Investigators.

Eur Heart J. 2009 Jul;30(14):1753-63. Epub 2009 May 12.PMID: 19435740 [PubMed - indexed for MEDLINE]Related articles

Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention.

Capranzano P, Ferreiro JL, Angiolillo DJ.

Expert Rev Cardiovasc Ther. 2009 Apr;7(4):361-9. Review.PMID: 19379060 [PubMed - indexed for MEDLINE]Related articles

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.

Price MJ, Berger PB, Angiolillo DJ, Teirstein PS, Tanguay JF, Kandzari DE, Cannon CP, Topol EJ.

Am Heart J. 2009 May;157(5):818-24, 824.e1.PMID: 19376306 [PubMed - indexed for MEDLINE]Related articles

Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions.

Angiolillo DJ.

Diabetes Care. 2009 Apr;32(4):531-40. Review. No abstract available. PMID: 19336638 [PubMed - indexed for MEDLINE]Related articlesFree article

Contemporary issues on clopidogrel therapy: a critical appraisal.

Capodanno D, Angiolillo DJ.

Intern Emerg Med. 2009 Jun;4(3):195-8. Epub 2009 Mar 31. No abstract available. PMID: 19333714 [PubMed - indexed for MEDLINE]Related articles

Platelet function testing in clinical practice: are we ready for prime time?

Angiolillo DJ.

Rev Esp Cardiol. 2009 Feb;62(2):113-6. English, Spanish. No abstract available. PMID: 19232182 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease.

Tamburino C, Angiolillo DJ, Capranzano P, Di Salvo M, Ussia G, La Manna A, Guzman LA, Galassi AR, Bass TA.

Catheter Cardiovasc Interv. 2009 Feb 15;73(3):291-8.PMID: 19214963 [PubMed - indexed for MEDLINE]Related articles

Advances in antiplatelet therapy: agents in clinical development.

Angiolillo DJ, Bhatt DL, Gurbel PA, Jennings LK.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):40A-51A. Review.PMID: 19166712 [PubMed - indexed for MEDLINE]Related articles

Variability in responsiveness to oral antiplatelet therapy.

Angiolillo DJ.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):27A-34A. Review.PMID: 19166710 [PubMed - indexed for MEDLINE]Related articles

Emerging insights on antiplatelet therapy. Introduction.

Angiolillo DJ.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):1A-3A. No abstract available. PMID: 19166706 [PubMed - indexed for MEDLINE]Related articles

Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromes.

Biasucci LM, Liuzzo G, Della Bona R, Leo M, Biasillo G, Angiolillo DJ, Abbate A, Rizzello V, Niccoli G, Giubilato S, Crea F.

Clin Chem. 2009 Feb;55(2):365-8.PMID: 19179271 [PubMed - indexed for MEDLINE]Related articles

Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.

Angiolillo DJ, Suryadevara S, Capranzano P, Zenni MZ, Guzman LA, Bass TA.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):1-14. Review.PMID: 19089929 [PubMed - indexed for MEDLINE]Related articles

Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.

Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, Sirbu V, Bass TA, Della Rovere F, Gavazzi A, Angiolillo DJ.

Am J Cardiol. 2008 Dec 15;102(12):1618-23. Epub 2008 Sep 24.PMID: 19064015 [PubMed - indexed for MEDLINE]Related articles

Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.

Angiolillo DJ, Capranzano P, Desai B, Shoemaker SB, Charlton R, Zenni MM, Guzman LA, Bass TA.

Thromb Res. 2009 Jul;124(3):318-22. Epub 2008 Nov 13.PMID: 19012950 [PubMed - indexed for MEDLINE]Related articles

Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development.

Angiolillo DJ, Suryadevara S, Capranzano P, Bass TA.

Expert Opin Pharmacother. 2008 Nov;9(16):2893-900. Review.PMID: 18937620 [PubMed - indexed for MEDLINE]Related articles

Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysis.

Jiménez-Quevedo P, Suzuki N, Corros C, Ferrer C, Angiolillo DJ, Alfonso F, Hernández-Antolín R, Bañuelos C, Escaned J, Fernández C, Costa M, Macaya C, Bass T, Sabaté M.

Diabetes. 2009 Jan;58(1):209-14. Epub 2008 Oct 1.PMID: 18829988 [PubMed - indexed for MEDLINE]Related articlesFree article

Hypertriglyceridemia and ischemic stroke.

Antonios N, Angiolillo DJ, Silliman S.

Eur Neurol. 2008;60(6):269-78. Epub 2008 Sep 27. Review.PMID: 18824854 [PubMed - indexed for MEDLINE]Related articles

Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.

Tamburino C, Angiolillo DJ, Capranzano P, Dimopoulos K, La Manna A, Barbagallo R, Tagliareni F, Mangiafico S, Guzman LA, Galassi AR, Bass TA.

Catheter Cardiovasc Interv. 2008 Oct 1;72(4):448-56.PMID: 18814218 [PubMed - indexed for MEDLINE]Related articles

Prognostic significance of troponin T elevation in patients without chest pain.

Carlson ER, Percy RF, Angiolillo DJ, Conetta DA.

Am J Cardiol. 2008 Sep 15;102(6):668-71. Epub 2008 Jun 26.PMID: 18773985 [PubMed - indexed for MEDLINE]Related articles

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.

Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FW, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe CH, Antman EM; TRITON-TIMI 38 Investigators.

Circulation. 2008 Oct 14;118(16):1626-36. Epub 2008 Aug 31.PMID: 18757948 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical overview of promising nonthienopyridine antiplatelet agents.

Angiolillo DJ, Guzman LA.

Am Heart J. 2008 Aug;156(2 Suppl):S23-8. Review.PMID: 18657683 [PubMed - indexed for MEDLINE]Related articles

Clinical profile of prasugrel, a novel thienopyridine.

Angiolillo DJ, Bates ER, Bass TA.

Am Heart J. 2008 Aug;156(2 Suppl):S16-22. Review.PMID: 18657682 [PubMed - indexed for MEDLINE]Related articles

Pharmacology of emerging novel platelet inhibitors.

Angiolillo DJ, Capranzano P.

Am Heart J. 2008 Aug;156(2 Suppl):S10-5. Review.PMID: 18657681 [PubMed - indexed for MEDLINE]Related articles

Current antiplatelet therapies: benefits and limitations.

Angiolillo DJ, Guzman LA, Bass TA.

Am Heart J. 2008 Aug;156(2 Suppl):S3-9. Review.PMID: 18657680 [PubMed - indexed for MEDLINE]Related articles

Platelet inhibitor therapy: current perspectives and emerging novel agents: introduction.

Angiolillo DJ, Bates ER.

Am Heart J. 2008 Aug;156(2 Suppl):S1-2.PMID: 18657679 [PubMed - indexed for MEDLINE]Related articles

A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.

Angiolillo DJ, Capranzano P, Goto S, Aslam M, Desai B, Charlton RK, Suzuki Y, Box LC, Shoemaker SB, Zenni MM, Guzman LA, Bass TA.

Eur Heart J. 2008 Sep;29(18):2202-11. Epub 2008 Jun 21.PMID: 18567918 [PubMed - indexed for MEDLINE]Related articlesFree article

Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design.

Valgimigli M, Campo G, de Cesare N, Vranckx P, Hamon M, Angiolillo DJ, Sabatè M, Ferrari F, Furgieri A, Tumscitz C, Repetto A, Colangelo S, Meliga E, Kubbajeh M, Parrinello G, Percoco G, Ferrari R.

Cardiovasc Drugs Ther. 2008 Aug;22(4):313-20. Epub 2008 Jun 17.PMID: 18561010 [PubMed - indexed for MEDLINE]Related articles

Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).

Costa MA, Angiolillo DJ, Tannenbaum M, Driesman M, Chu A, Patterson J, Kuehl W, Battaglia J, Dabbons S, Shamoon F, Flieshman B, Niederman A, Bass TA; STLLR Investigators.

Am J Cardiol. 2008 Jun 15;101(12):1704-11. Epub 2008 Apr 9.PMID: 18549844 [PubMed - indexed for MEDLINE]Related articles

Short- or long-term outcomes of coronary artery aneurysms occurring after directional coronary atherectomy.

Oikawa Y, Yajima J, Angiolillo DJ, Akabane M, Funada R, Matsuno S, Inaba T, Nakagawa Y, Nakamura M, Sawada H, Aizawa T.

J Invasive Cardiol. 2008 Apr;20(4):159-60.PMID: 18398229 [PubMed - indexed for MEDLINE]Related articlesFree article

Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.

Rossini R, Angiolillo DJ, Musumeci G, Scuri P, Invernizzi P, Bass TA, Mihalcsik L, Gavazzi A.

Am J Cardiol. 2008 Mar 15;101(6):786-9. Epub 2008 Feb 21.PMID: 18328841 [PubMed - indexed for MEDLINE]Related articles

Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment.

Angiolillo DJ, Costa MA, Shoemaker SB, Desai B, Bernardo E, Suzuki Y, Charlton RK, Zenni MM, Guzman LA, Bass TA.

Am J Cardiol. 2008 Feb 15;101(4):440-5. Epub 2007 Dec 20.PMID: 18312754 [PubMed - indexed for MEDLINE]Related articles

Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.

Angiolillo DJ, Bernardo E, Palazuelos J, Desai B, Weisberg I, Alfonso F, Guzman LA, Hernández-Antolin R, Zenni MZ, Macaya C, Fernandez-Ortiz A, Bass TA.

Thromb Haemost. 2008 Jan;99(1):161-8.PMID: 18217149 [PubMed - indexed for MEDLINE]Related articles

Variable histological and ultrasonic characteristics of restenosis after drug-eluting stents.

Suzuki N, Angiolillo DJ, Monteiro C, Shuja S, Futamatsu H, Kawaguchi R, Box LC, Guzman L, Zenni MM, Gilmore PS, Bass TA, Costa MA.

Int J Cardiol. 2008 Nov 28;130(3):444-8. Epub 2008 Jan 15.PMID: 18199506 [PubMed - indexed for MEDLINE]Related articles

A systematic review of outcomes in patients with staged carotid artery stenting and coronary artery bypass graft surgery.

Guzman LA, Costa MA, Angiolillo DJ, Zenni M, Wludyka P, Silliman S, Bass TA.

Stroke. 2008 Feb;39(2):361-5. Epub 2008 Jan 3. Review.PMID: 18174484 [PubMed - indexed for MEDLINE]Related articlesFree article

ADP receptor antagonism: what's in the pipeline?

Angiolillo DJ.

Am J Cardiovasc Drugs. 2007;7(6):423-32. Review.PMID: 18076209 [PubMed - indexed for MEDLINE]Related articles

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.

Wiviott SD, Trenk D, Frelinger AL, O'Donoghue M, Neumann FJ, Michelson AD, Angiolillo DJ, Hod H, Montalescot G, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Braunwald E; PRINCIPLE-TIMI 44 Investigators.

Circulation. 2007 Dec 18;116(25):2923-32. Epub 2007 Dec 3.PMID: 18056526 [PubMed - indexed for MEDLINE]Related articlesFree article